bioMérieux S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMXMF research report →
About the company
Operating on a global scale, bioMérieux S. A. designs and produces in vitro diagnostic solutions specifically for detecting infectious diseases across the Americas, Europe, the Middle East, Africa, and Asia Pacific.
- CEO
- Pierre Boulud
- IPO
- 2017
- Employees
- 14,147
- HQ
- Marcy l'Étoile, FR
Price Chart
- Market Cap
- $9.19B
- P/E
- 20.66
- P/S
- 2.02
- P/B
- 2.00
- EV/EBITDA
- 8.53
- Div Yield
- 1.41%
- Gross Margin
- 53.07%
- Op Margin
- 9.54%
- Net Margin
- 9.76%
- ROE
- 9.89%
- ROIC
- 6.32%
- Revenue
- $4.07B · 2.22%
- Net Income
- $397.35M · -8.06%
- EPS
- $3.37 · -8.17%
- Op Income
- $654.45M
- FCF YoY
- 40.85%
- 52W High
- $152.00
- 52W Low
- $77.00
- 50D MA
- $83.53
- 200D MA
- $111.90
- Beta
- 0.57
- Avg Volume
- 222
Get TickerSpark's AI analysis on BMXMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BMXMF coverage
Recent articles, reports, and earnings notes.
No research on BMXMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMXMF report →Similar companies
Peers in the same neighborhood.